Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double-blind, controlled trial
Open accessAbstract
Background: The stability of hemodynamics during anesthesia induction in patients undergoing valve replacement surgery is particularly important. Remimazolam is a new type of benzodiazepine drug, with supposed advantages of rapid induction, rapid recovery, stable hemodynamics, and mild respiratory inhibition. Aim: To evaluate the effect of remimazolam anesthesia induction on hemodynamics in patients undergoing valve replacement surgery. Methods: This randomized, double‐blind, controlled trial enrolled consecutive patients undergoing mitral valve replacement (MVR)/aortic valve replacement (AVR)/double‐valve replacement (DVR) surgery on cardiopulmonary bypass (CPB). The study was conducted according to the Consolidated Standards of Reporting Trials statement. Participants were randomly assigned to receive either remimazolam or propofol induction of 30 patients each. All patients, data collectors, and data analyzers were blinded to the group allocation. The primary outcomes were the fluctuations in hemodynamic parameters (the difference of maximum or minimum heart rate to baseline, ▲HR, the difference of maximum or minimum mean arterial pressure to baseline, ▲MAP), the occurrence of cardiovascular events (hypotension, severe bradycardia), and the cumulative norepinephrine doses used per patient, averaged per group during induction. The secondary outcomes were hemodynamic parameters (heart rate, HR, mean arterial pressure, MAP, bispectral index, BIS, plasma lactic acid, Lac, and blood glucose, Glu values). Results: A total of 60 patients with heart valve replacement were included in the final analysis, with 30 patients in each group. The ▲MAP was significantly lower in the remimazolam group than in the propofol group during induction ( p < .05). The incidences of hypotension and the cumulative norepinephrine doses used per patient, averaged per group during induction were significantly lower in the remimazolam group than in the propofol group ( p < .05). Conclusion: Remimazolam may be safe and effective for induction and may as an alternative to propofol during anesthesia induction in patients undergoing valve replacement surgery.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The remimazolam group had a lower ΔHR than the propofol group (MD = -4.99; 95% CI, -7.97 to -2.00; I2 = 42%; P = 0.001).
“Our statistical analysis revealed significant discrepancies between the 2 groups, wherein the remimazolam group having a lower 𝛥 HR (MD = -4.99; 95% CI, -7.97 to -2.00; I² = 42%; P = 0.001) (Fig. 4).”
From Hemodynamic Influences of Remimazolam Versus Propofol During the Induction Period of General Anesthesia: A Systematic Review and Meta-analysis of Randomized Controlled Trials (2023) · cites this paper as [21]
The Results (Primary outcomes, Table 2) state that ΔHR did not differ significantly between groups. In this trial, the remimazolam group had a numerically higher ΔHR than the propofol group (9.3 versus 6.5 beats/min; p = .238), contrary to the claimed lower ΔHR. The reported pooled MD, confidence interval, and I² are not results of this trial. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredAfter removing Liu et al. (21), the lower ΔHR in the remimazolam group persisted (MD = -6.03, 95% CI: -9.22 to -2.85, I2 = 0%, P = 0.0002).
“Upon removal of the study by Liu et al (21), a substantial dissimilarity in 𝛥 HR between the 2 study arms persisted, thereby bolstering the position of the remimazolam group (MD = -6.03, 95% CI: -9.22 to -2.85, I² = 0%, P = 0.0002).”
Risk of bias was moderate in 5 papers for other biases because of singular gender or type of surgery.
“The risk of bias was rated as moderate in 5 papers for the domain of other biases because of their singular gender or type of surgery (15,19-22).”
Five of the included trials were regarded as high-quality.
“Among these trials, 5 were regarded high-quality (18-22) (Figs. 2, 3).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Epidemiology of valvular heart disease in the adult
Iung, B., & Vahanian, A. S. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.202 · Cited by 727 · cited 2× · see citing works
“The inclusion criteria were as follows: (1) Scheduled for MVR/AVR/DVR on CPB; (2) Age 35– 65 years; (3) Cardiac function graded as New York Heart Association class II or III; and (4) American Society of Anesthesiologists (ASA) grade III.”
BackgroundMethodDoi, M., Morita, K., Takeda, J., Sakamoto, A., Yamakage, M., & Suzuki, T. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02788-6 · Cited by 484 · see citing works
Antonik, L. J., Goldwater, D. R., Kilpatrick, G., Tilbrook, G., & Borkett, K. (2012) · Anesthesia and Analgesia · doi:10.1213/ane.0b013e31823f0c28 · Cited by 321 · see citing works
Pastis, N., Yarmus, L., Schippers, F., Ostroff, R., Chen, A. C., Akulian, J., Wahidi, M., Shojaee, S., Tanner, N., Callahan, S., et al. (2019) · Chest · doi:10.1016/j.chest.2018.09.015 · Cited by 289 · see citing works
Rex, D., Bhandari, R., Desta, T., Demicco, M., Schaeffer, C., Etzkorn, K., Barish, C., Pruitt, R., Cash, B., Quirk, D., et al. (2018) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.04.2351 · Cited by 260 · see citing works
Tan, C. H., & Onsiong, M. K. (1998) · Anaesthesia · doi:10.1046/j.1365-2044.1998.00405.x · Cited by 244 · see citing works
Doi, M., Hirata, N., Suzuki, T., Morisaki, H., Morimatsu, H., & Sakamoto, A. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02776-w · Cited by 242 · see citing works
An audit of audit and continued educational and professional development
Clark, M. X., Knights, D., & Henley, M. (2001) · Anaesthesia · doi:10.1111/j.1365-2044.2001.02279.x · Cited by 220
Wiltshire, H. R., Kilpatrick, G. J., Tilbrook, G. S., & Borkett, K. M. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318241f68a · Cited by 215 · see citing works
Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology
Wesołowski, A., Zaccagnino, M. P., Malapero, R. J., Kaye, A., & Urman, R. (2016) · Pharmacotherapy · doi:10.1002/phar.1806 · Cited by 191 · see citing works
Keam, S. J. (2020) · Drugs · doi:10.1007/s40265-020-01299-8 · Cited by 188 · cited 1× · see citing works
“The exclusion criteria were as follows: (1) Severe cardiac dysfunction, ASA grade IV or above; (2) Allergic or contraindicated to benzodiazepines, opioids, propofol or their components; (3) Hypertension of grade 3 or above; (4) Dysfunction of the liver or kidney; and (5) Participation in another study within 4 weeks b…”
BackgroundObara, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737217924.793576094 · Cited by 124
Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!!
Masui, K. (2020) · Journal of Anesthesia · doi:10.1007/s00540-020-02755-1 · Cited by 123 · see citing works
Bendel, S., Ruokonen, E., Pölönen, P., & Uusaro, A. (2007) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2006.01206.x · Cited by 78
Recent Developments in Drugs for GI Endoscopy Sedation
Goudra, B., Gouda, G., & Mohinder, P. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06044-5 · Cited by 72 · see citing works
Kleiman, R. B., Darpo, B., Thorn, M., Stoehr, T., & Schippers, F. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14270 · Cited by 37 · see citing works
New Hypnotic Drug Development and Pharmacologic Considerations for Clinical Anesthesia.
Tanious, M. K., Beutler, S. S., Kaye, A., & Urman, R. (2017) · Anesthesiology Clinics · doi:10.1016/j.anclin.2017.01.017 · Cited by 27 · see citing works
Sato, T., Kato, Y., Yamamoto, M., & Nishiwaki, K. (2020) · JA Clinical Reports · doi:10.1186/s40981-020-00398-5 · Cited by 23 · see citing works
Cardiac remodeling in aortic and mitral valve disease: a simulation study with clinical validation.
Maksuti, E., Westerhof, B., Ugander, M., Donker, D. W., Carlsson, M., & Broomé, M. (2019) · Journal of applied physiology · doi:10.1152/japplphysiol.00791.2018 · Cited by 19 · see citing works
Anesthetic Considerations for the Transcatheter Management of Mitral Valve Disease.
Gregory, S. H., Sodhi, N., Zoller, J. K., Quader, N., Ridley, C. H., Maniar, H. S., Lasala, J., & Zajarías, A. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.05.054 · Cited by 18 · cited 2×
“The inclusion criteria were as follows: (1) Scheduled for MVR/AVR/DVR on CPB; (2) Age 35– 65 years; (3) Cardiac function graded as New York Heart Association class II or III; and (4) American Society of Anesthesiologists (ASA) grade III.”
BackgroundMethodDai, Z.-L., Cai, X., Gao, W., Lin, M., Lin, J., Jiang, Y.-X., & Jiang, X. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i6.1293 · Cited by 15
Flagged first, then by citations
2 of the 23 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- [1]Domenech B, Pomar JL, Prat‐González S, et al. Valvular heart disease epidemics. J Heart Valve Dis. 2016; 25: 1‐ 7. 29505225
- [2]Hollenberg SM. Valvular heart disease in adults: etiologies, classification, and diagnosis. FP Essent. 2017; 457: 11‐ 16. 28671804
- [9]Eisenried A, Schüttler J, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology. 2020; 132: 652‐ 666. 31972657
Cited by
Sorted by citations
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Bartolomaeus, H., Balogh, A., Yakoub, M., Homann, S., Markó, L., Höges, S., Tsvetkov, D., Krannich, A., Wundersitz, S., Avery, E. G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036652 · Cited by 822 · see citing works
Remimazolam: An Updated Review of a New Sedative and Anaesthetic
Hu, Q.-X., Liu, X., Wen, C., Li, D., & Lei, X.-F. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s384155 · Cited by 185 · see citing works
“pharmacologically inactive, it does not affect liver and kidney function and can be safely used among patients with impaired liver or renal function.(28,29) No significant differences were observed in the pharmacokinetics of remimazolam between healthy individuals and patients with end-stage renal disease.”
BackgroundRemimazolam – current knowledge on a new intravenous benzodiazepine anesthetic agent
Kim, S.-H., & Fechner, J. (2022) · Korean Journal of Anesthesiology · doi:10.4097/kja.22297 · Cited by 136 · see citing works
“[24] compared two groups of 30 patients each that were induced with remimazolam 0.”
Ko, C.-C., Hung, K.-C., Illias, A. M., Chiu, C., Yu, C.-H., Lin, C.-M., Chen, I.-W., & Sun, C.-K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1101728 · Cited by 94 · see citing works
“Of the eight studies involving operations under general anesthesia with tracheal intubation, six involved non-cardiac procedures and two focused on valve surgery (Liu et al., 2021; Tang et al., 2021).”
BackgroundMethodInfluentialQiu, Y., Gu, W., Zhao, M., Zhang, Y.-Y., & Wu, J.-X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.938940 · Cited by 77 · see citing works
Nakanishi, T., Sento, Y., Kamimura, Y., Tsuji, T., Kako, E., & Sobue, K. (2021) · BMC Anesthesiology · doi:10.1186/s12871-021-01530-3 · Cited by 70 · see citing works
“Although remimazolam was reported to be less hypotensive than propofol [9, 11], it should be noted that remimazolam can cause moderate hypotension after LoC.”
BackgroundMethodTang, Y., Yang, X.-B., Yu, Y., Shu, H.-Q., Yuan, Y., Liu, H., Zou, X., Yuan, S.-Y., & Shang, Y. (2022) · Critical Care · doi:10.1186/s13054-022-04168-w · Cited by 56
“Studies have shown that remimazolam besylate was expected to be relatively safe with regard to potential risks of cardiovascular depression complications [11, 12].”
BackgroundKuang, Q., Zhong, N., Ye, C.-S., Zhu, X.-P., & Wei, F.-S. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.06.027 · Cited by 46 · see citing works
Xin, Y., Chu, T., Wang, J., & Xu, A. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01805-3 · Cited by 45 · see citing works
Takaki, R., Yokose, M., Mihara, T., Saigusa, Y., Tanaka, H., Yamamoto, N., Masui, K., & Goto, T. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.04.013 · Cited by 45 · see citing works
Hu, B.-L., Zhang, M., Wu, Z., Zhang, X.-Y., Zou, X., Tan, L., Song, T., & Li, X. (2023) · Drug Design, Development and Therapy · doi:10.2147/dddt.s401969 · Cited by 44 · see citing works
“3mg/kg) on hemodynamic fluctuation was significantly smaller than that of propofol in patients who underwent cardiac surgery.(17) In another study, Zhang et al demonstrated that the influence of RT (0.”
BackgroundZhu, T. (2023) · Pain Physician Journal · doi:10.36076/ppj.2023.26.e761 · Cited by 37 · see citing works
Lee, B., Kim, M., Kong, H.-J., Shin, H., Yang, S.-H., Kim, N. Y., & Chae, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092643 · Cited by 36 · see citing works
“Among its many advantages, hemodynamic stability has been proposed as the main benefit [6,11].”
BackgroundResultZhang, J.-B., Zhang, J.-X., Wang, Y.-Y., Bai, X.-G., Guo, Q., Liu, W., Li, H., Zhu, F.-Q., Wang, X., Jiang, X.-F., et al. (2023) · Journal of clinical anesthesia · doi:10.1016/j.jclinane.2023.111356 · Cited by 33 · see citing works
Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress
Wang, M., Zhao, X., Yin, P., Bao, X.-X., Tang, H.-L., & Kang, X. (2022) · Drug Design, Development and Therapy · doi:10.2147/dddt.s375957 · Cited by 32 · see citing works
“A recently published double-blind clinical trial explored the effect of remimazolam anesthesia induction on hemodynamics in patients undergoing valve replacement.(29) A total of 60 patients were randomly assigned to the remimazolam group (0.”
Remimazolam in a Pediatric Patient With a Suspected Family History of Malignant Hyperthermia
Petkus, H., Willer, B., & Tobias, J. (2022) · Journal of Medical Cases · doi:10.14740/jmc3977 · Cited by 31 · see citing works
“Following the successful use of remimazolam as the primary agent for procedural sedation, there has also been preliminary experience with its use as a supplement to general anesthesia during intraoperative care [11-15].”
BackgroundRemimazolam and serious adverse events
Kempenaers, S., Hansen, T. G., & de Velde, M. V. (2023) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001902 · Cited by 30 · see citing works
Pan, Y., Chen, M., Gu, F., Chen, J.-Y., Zhang, W., Huang, Z., Zhu, D., Song, J., Fang, J., Yu, W., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010257 · Cited by 29 · see citing works
Self-citationNam, S. W., Yim, S., Choi, C. I., Park, I., Joung, K.-W., & Song, I. (2023) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-023-02514-2 · Cited by 29 · see citing works
“Remimazolam vs propofol use also reduces the incidence of hypotension and cumulative norepinephrine requirement in patients undergoing valve replacement surgery.(4)”
BackgroundLee, S., Lee, J., Hwang, S. Y., Ju, J., Nam, K., Ahn, H., Lee, S.-R., Choi, E., Jeon, Y., & Cho, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-63578-8 · Cited by 25
Remimazolam and Its Place in the Current Landscape of Procedural Sedation and General Anesthesia
Brohan, M., Brohan, J., & Goudra, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154362 · Cited by 23 · see citing works
“A randomized controlled trial by Liu et al. demonstrated that the change in mean arterial pressure in elderly patients undergoing aortic valve replacement was lower in the group treated with remimazolam than in those treated with propofol [74].”
ResultHuang, Y.-Q., Yan, T., Lu, G.-H., Luo, H., Lai, Z.-M., & Zhang, L. (2023) · BMC Anesthesiology · doi:10.1186/s12871-023-02364-x · Cited by 23 · see citing works
“Although many studies have reported that remimazolam is preferred to propofol in hemodynamic stability, they mainly target healthy people and patients undergoing gastro-endoscopy and cardiac surgery [28–32], and studies on patients with hypertension have not been reported.”
BackgroundPark, I., Cho, M., Nam, S., Hwang, J.-W., Do, S., & Na, H. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01779-2 · Cited by 23 · see citing works
“Remimazolam is known to cause less cardiovascular depression than propofol during general anesthesia [10, 18].”
BackgroundJu, J., Lee, D.-J., Chung, J., Lee, S., Cho, Y., Jeon, Y., & Nam, K. (2024) · Journal of clinical anesthesia · doi:10.1016/j.jclinane.2024.111580 · Cited by 22
Tang, L., Sun, Y., Hao, X., Sun, X., Xie, C., Wang, T., Hu, C., Lu, Y., & Liu, X.-S. (2023) · BJA Open · doi:10.1016/j.bjao.2023.100237 · Cited by 22 · see citing works
“Physical independence and psychological support, two of the five QoR-15 domains, were also higher in the R group (8.5 [8 e 10] vs 8 [7 e 9], P ¼ 0.043; 17 [13 e 17] vs 12.5 [12 e 14], P < 0.001).”
BackgroundResultInfluentialSelf-citationComparison of remimazolam and propofol induction on hemodynamic response in hypertensive patients
Choi, E., Jang, Y.-J., & Park, S.-J. (2023) · Medicine · doi:10.1097/md.0000000000034358 · Cited by 22 · see citing works
“during general anesthesia.[9,13] However, no studies have compared the induction period hemodynamics of remimazolam and propofol in patients with hypertension.”
BackgroundYim, S.-H., Choi, C.-I., Park, I., Koo, B., Oh, A.-Y., & Song, I. (2024) · Canadian Journal of Anesthesia/Journal canadien d'anesthésie · doi:10.1007/s12630-024-02735-z · Cited by 21 · see citing works
“7 We planned to perform intention-to-treat analyses.”
He, M.-F., Gong, C.-J., Chen, Y.-N., Chen, R.-B., & Qian, Y.-N. (2023) · Journal of Biomedical Research · doi:10.7555/jbr.37.20230110 · Cited by 20
Self-citationRemimazolam in Cardiac Anesthesia: Analysis of Recent Data.
Ripoll, J. G., Orjuela, R. B., Kanaparthi, A., Soto, J. C. D., ElSaban, M., Peclat, T. R., Wieruszewski, P., Abcejo, A. S., Chang, M. G., Bittner, E. A., et al. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.08.030 · Cited by 19 · see citing works
Yi, F.-X., Xiao, H.-H., Zhu, T., Man, Y., & Ji, F.-C. (2022) · BMC Anesthesiology · doi:10.1186/s12871-022-01835-x · Cited by 19 · see citing works
Liu, X., Shui, G.-J., Wang, Y., Chen, T., Zhang, P., Liu, L., Li, C.-H., Li, T., & Wang, X. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5498 · Cited by 18 · see citing works
“A recent clinical study demonstrated that Rema alleviated the surgical stress response in cardiac surgery and adverse cardiac reactions; however, the specific underlying mechanisms are yet to be fully understood (14,15).”
Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review
Tobias, J. D. (2024) · Paediatric anaesthesia · doi:10.1111/pan.14970 · Cited by 18 · see citing works
“29 Nam and colleagues retrospectively compared the effects of remimazolam versus desflurane on the hemodynamic changes and doses of vasoactive agents during general anesthesia for cardiac ablation for atrial fibrillation.”
Fujimoto, D., Obata, N., & Mizobuchi, S. (2024) · Journal of Anesthesia · doi:10.1007/s00540-024-03339-z · Cited by 18 · see citing works
Chen, J.-J., Zou, X., Hu, B.-L., Yang, Y., Wang, F., Zhou, Q., & Shen, M. (2023) · Drug Design, Development and Therapy · doi:10.2147/dddt.s425590 · Cited by 18 · see citing works
Self-citationChoi, S.-H., Min, K., Park, E. K., & Park, S. (2024) · BMC Anesthesiology · doi:10.1186/s12871-024-02578-7 · Cited by 17
“According to Liu et al. [23], the incidence of hypotension during induction was 16.7% for remimazolam and 43.3% for propofol.”
BackgroundInfluentialLee, S.-H., Kang, H.-Y., Ahn, Y. N., & You, A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050789 · Cited by 16 · see citing works
Xing, Y., Lang, Z.-K., Wang, X.-R., Liu, J., Han, X.-X., Zhou, J., & Leng, Y.-F. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002737 · Cited by 15 · see citing works
Koo, C.-H., Lee, S.-U., Kim, H., Lee, S., Bae, Y., Oh, A.-Y., Jeon, Y.-T., & Ryu, J.-H. (2025) · Korean Journal of Anesthesiology · doi:10.4097/kja.24538 · Cited by 15 · see citing works
“In patients undergoing cardiac surgery, it has been report-ed that this new drug provides greater hemodynamic stability than propofol, as indicated by a lower occurrence rate of hypotension and evidence of a reduced need for vasoactive agents [12,13].”
Xiao, Y.-Y., Zou, H.-D., Qin, X.-J., Zhu, R., & Dai, R.-P. (2024) · Anesthesia and Analgesia · doi:10.1213/ane.0000000000007309 · Cited by 15 · see citing works
“11.0), we set the assumed mean difference at 9.2 mm Hg, with an SD of 9.1 mm Hg (assuming equal variance), with a significance level of 0.025 and 90% power, and accounting for a 20% drop-out rate, a sample size of 40 patients per group was estimated.”
InfluentialAnti‐inflammatory potential of remimazolam: A laboratory and clinical investigation
Tsukimoto, S., Kitaura, A., Kuroda, H., Imaizumi, U., Yoshino, F., Yoshida, A., Nakao, S., Ohta, N., Nakajima, Y., & Sanuki, T. (2024) · Immunity, Inflammation and Disease · doi:10.1002/iid3.1218 · Cited by 15
Qu, L., Liu, M., Ouyang, R., Li, T., Long, D., Jiang, Y., Wang, C.-Y., & Cheng, L.-Q. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1136003 · Cited by 15
Kim, K. M., Bang, J.-Y., Lee, J.-M., Yang, H., Choi, B.-M., & Noh, G.-J. (2022) · Anesthesia and Pain Medicine · doi:10.17085/apm.21121 · Cited by 15
So, K., Park, J., & Kim, S. H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1265860 · Cited by 14 · see citing works
Ko, E., Je, L., Kim, J., Song, Y. J., & Lim, C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133958 · Cited by 13
“The most notable advantage of remimazolam as a general anesthetic agent is its lower cardiovascular depressant effect than that of propofol or inhalation anesthetic agents [7–9].”
BackgroundJeong, H., Kim, H.-R., & Ahn, H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051763 · Cited by 13 · see citing works
“Patients who were induced by remimazolam showed a significantly lower incidence of hypotensive adverse events [9,10], and less need for vasopressors compared to patients who were induced by propofol [11].”
BackgroundBenefits of remimazolam as an anesthetic sedative for older patients: A review
Jin, N., & Xue, Z.-Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25399 · Cited by 12 · see citing works
“…acid and glucose levels of patients who received propofol, there were no significant changes in patients who received remimazolam before and after tracheal intubation; additionally, there was no hypoxia or excessive stress leading to tissue perfusion dysfunction during the induction process [68].”
BackgroundRemimazolam Use in Cardiac Anesthesia: A Narrative Review.
Muncan, B., & Bennett-Guerrero, E. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.07.045 · Cited by 11 · see citing works
Hong, S., Park, J.-Y., Rhee, K. Y., & Kim, S.-H. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.95736 · Cited by 10 · see citing works
Huang, L., Liu, H., Zou, X., Ding, J., & Tao, S. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02820-1 · Cited by 11 · see citing works
Remimazolam for cardiovascular anesthesia
Hirata, N. (2023) · Journal of Anesthesia · doi:10.1007/s00540-023-03242-z · Cited by 11
Luo, H., & Tang, Z.-L. (2024) · Biomedical Reports · doi:10.3892/br.2024.1891 · Cited by 10 · see citing works
“It also decreases surgical stress response and respiratory depression without significant myocardial depression, resulting in fewer anesthesia‑associated adverse reac‑ tions (23,31,35).”
Ito, H., Kameyama, A., Furuta, M., Yoshida, M., Onishi, K., & Kawakami, M. (2022) · Cureus · doi:10.7759/cureus.30706 · Cited by 10
“A small randomized control trial reported that anesthesia induction with remimazolam during cardiac surgery was associated with fewer fluctuations in mean blood pressure [5].”
BackgroundNovel anesthetics in pediatric practice: is it time?
Useinovic, N., & Jevtovic-Todorovic, V. (2022) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001156 · Cited by 10 · see citing works
“In patients undergoing valve replacement surgery, induction of anesthesia with remimazolam resulted in significantly fewer hypotensive episodes and a decreased use of vasopressors [26].”
Chen, L., Qin, W., Wu, J.-D., Zhao, G., Jiang, X., Li, M., Huang, Z.-J., & Du, X.-K. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s464530 · Cited by 9
“This may be due to the small impact of benzodiazepines on myocardial contractility and a slight increase in HR. 20 In addition, remimazolam can reduce autonomic nervous system activity during general anesthesia induction and maintain a balance of sympathetic and parasympathetic nervous system…”
BackgroundTsukimoto, S., Kitaura, A., Yamamoto, R., Hirase, C., Nakao, S., Nakajima, Y., & Sanuki, T. (2024) · Cureus · doi:10.7759/cureus.58340 · Cited by 7 · see citing works
Deng, W., Zeng, Z., Liu, Q., Deng, J., Wang, L., Li, H., & Zhang, Y.-N. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s459885 · Cited by 8
“With the advancement and establishment of laparoscopic minimally invasive technology alongside the formulation of guidelines for rapid rehabilitation surgery, 1,2 laparoscopic surgery has been increasingly adopted in clinical practice.”
MethodTakahashi, Y., Yoshii, R., Amaya, F., Sawa, T., & Ogawa, S. (2023) · Journal of Anesthesia · doi:10.1007/s00540-023-03290-5 · Cited by 8
Hu, X.-Y., Wang, B.-B., Hu, L., Han, D.-S., & Wu, J. (2023) · Drug Design, Development and Therapy · doi:10.2147/dddt.s411829 · Cited by 8 · see citing works
Kim, Y., Heo, H., Lee, J.-H., Cho, H., & Kim, G. (2022) · Medicina · doi:10.3390/medicina58111680 · Cited by 8
Liu, T., Qin, L., Su, M., Wei, Y., Yu, H., Wei, H.-T., Xie, Y.-B., & Chen, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-08403-6 · Cited by 7
“Several studies have shown that remimazolam reduces the occurrence of hypotension during anesthesia in elderly patients compared to propofol 5–7 .”
Self-citationChen, F., Xing, F., Huang, J., Zhu, J.-W., Jiang, Y., & Li, C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1545736 · Cited by 7
Li, S.-T., Zhang, Y., Wang, H.-B., Ye, G., Yao, N., & Zhu, X. (2023) · Anaesthesia, Pain & Intensive Care · doi:10.35975/apic.v27i6.2341 · Cited by 7
“21 20-23 This study provided more reliable evidence for the use of remimazolam as the best option for patients receiving outpatient painless endoscopy.”
BackgroundAnesthetic Management Using Remimazolam in a Hemodialysis Patient.
Nishioka, Y., Miyake, S., Hamaoka, M., Miyake, K., Fujimoto, M., Higuchi, H., & Miyawaki, T. (2023) · Anesthesia Progress · doi:10.2344/anpr-70-02-06 · Cited by 7 · see citing works
Saito, J., & Hirota, K. (2026) · Journal of Intensive Care · doi:10.1186/s40560-026-00849-8 · Cited by 6
Liu, T., Chen, J., Shi, M., Li, C., Dai, W., Chen, C., & Xie, Y.-B. (2025) · Scientific Reports · doi:10.1038/s41598-025-31205-9 · Cited by 6
“…randomized controlled trial showed that remimazolam induction causes less hemodynamic fluctuation in patients undergoing cardiac valve replacement surgery compared to propofol 46 —a critical advantage for stroke patients, who are highly sensitive to hypotension-induced cerebral hypoperfusion.”
Self-citationSeong, H., Cho, J., Yoon, S. Z., & Choi, S.-U. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216407 · Cited by 6
“Most importantly, remimazolam has minimal cardio-vascular depressant effects and can reduce the incidence of hypotension [8,9].”
BackgroundResultTsuji, Y., Koshika, K., & Ichinohe, T. (2024) · Journal of dental anesthesia and pain medicine · doi:10.17245/jdapm.2024.24.4.273 · Cited by 6
“We believe this is the reason for the higher HR and tendency of SBP to remain higher in Group R than in Group P. Remimazolam has been reported to show lower incidence rates of hypotension during general anesthesia induction than propofol [17].”
BackgroundOyoshi, T., Mitsuta, Y., Uemura, Y., Tajima, K., & Hirata, N. (2023) · JA Clinical Reports · doi:10.1186/s40981-023-00662-4 · Cited by 6 · see citing works
“Remimazolam provides favorable circulatory stability and is safely used in cardiac surgery [8–10].”
BackgroundSong, Y., & Zou, X. (2023) · European Review for Medical and Pharmacological Sciences · doi:10.26355/eurrev_202308_33399 · Cited by 6
Hu, B.-L., Zhou, H.-Y., Zou, X., Tan, L., Song, T., Zellmer, L., & Li, X. (2022) · Trials · doi:10.1186/s13063-022-06962-x · Cited by 6
“A recent study showed that remimazolam was superior to propofol during anesthesia induction in patients undergoing valve replacement surgery [28].”
BackgroundLiang, K., Nong, X.-L., Liang, Z.-J., Rana, N., Chen, N.-Q., & Lin, Y.-N. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03322-5 · Cited by 5
“Given the cardiovascular depressive effects of anesthetic agents, the decrease in blood pressure and HR observed during anesthesia induction in both groups was anticipated [24].”
Remimazolam mitigates oxidative stress response in patients undergoing one-lung ventilation
Li, S.-S., Sana, S., & Wang, D. (2025) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1456827 · Cited by 5
“In cardiac valve replacement surgery, remimazolam resulted in lower hemodynamic fl uctuations, hypotension, and norepinephrine usage compared to propofol (24).”
Kim, J., Lee, S., Yoo, B. H., Lim, Y., & Jun, I. (2025) · Medicina · doi:10.3390/medicina61020336 · Cited by 5 · see citing works
“It is hemodynamically stable, causing fewer incidences of hypotension in elderly patients during anesthesia induction than propofol [15].”
Yamamoto, S., Oyama, Y., Sasaki, M., Miyagoshi, M., Matsumoto, S., & Kitano, T. (2023) · JA Clinical Reports · doi:10.1186/s40981-023-00645-5 · Cited by 5
“A previous study suggested that the likelihood of hypotension is lower with remimazolam than with propofol in patients with heart failure of NYHA class II or III [3].”
BackgroundEffective concentration of remifentanil for successful i-gel insertion during remimazolam induction
Choi, J.-J., Jung, W., Chang, Y., Yoo, S., & Kwak, H. (2022) · Korean Journal of Anesthesiology · doi:10.4097/kja.22606 · Cited by 5
Jeong, H., & Ahn, H. J. (2025) · Korean Journal of Anesthesiology · doi:10.4097/kja.25446 · Cited by 4
Huang, J., Huang, H., Gao, H.-X., Lin, L.-R., Ling, X., Zhou, Q., & Lin, X.-Z. (2025) · Current Medical Science · doi:10.1007/s11596-025-00111-6 · Cited by 4
“This cardioprotective profile extends to high-risk populations including older adults [37] and cardiac surgery patients [38].”
Model-Informed Precision Dosing of Remimazolam in General Anesthesia Patients
Chen, Y.-T., Zhang, Z., Zhang, X.-F., Peng, Y., Jiao, Z., & Wu, J.-X. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s495604 · Cited by 4 · see citing works
“Other studies 6,7 have also indicated that during heart valve surgery and coronary artery bypass grafting, remimazolam provides more hemodynamically stable conditions during anesthesia induction compared to propofol, while also reducing the dosage of vasopressors required.”
Self-citationKim, S. H., Yoon, S. M., Ahn, J.-H., & Choi, Y. (2025) · Medicina · doi:10.3390/medicina61030523 · Cited by 4
“Another study comparing propofol and remimazolam found no significant differences in lactic acid and glucose levels before and after tracheal intubation in patients receiving remimazolam [33].”
Effect of remimazolam on intra-operative hypotension
He, T.-Y., Zhong, R.-P., Zhong, W.-B., Huang, G.-M., & Liu, X.-C. (2024) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000002057 · Cited by 4 · see citing works
Kurita, S., Furutani, K., Mitsuma, Y., Deguchi, H., Kamoda, T., Kamiya, Y., & Baba, H. (2024) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000983 · Cited by 4
“11,12 Although a previous report suggested that midazolam might have an inhibitory effect on MEPs, the inhibition might be milder than that of propofol.”
Kaneko, R., Koshika, K., Shionoya, M., Shimizu, K., Sendai, Y., Matsuura, N., & Ichinohe, T. (2024) · Anesthesia Progress · doi:10.2344/23-00002 · Cited by 4
Kim, B., Kim, M. S., Lee, J. H., Lee, D., Kim, H.-B., Oh, S., & Kim, H. (2022) · Medicina · doi:10.3390/medicina58101372 · Cited by 4
“Other recent studies have reported that remimazolam induces general anesthesia without hemodynamic instability in patients undergoing transcatheter aortic valve replacement or surgical aortic/mitral valve replacement [7,9].”
BackgroundRemimazolam for Procedural Sedation During Cardioversion
Hughes, M., Kramer, C., Corridore, M., McKee, C., & Tobias, J. D. (2025) · Cardiology Research · doi:10.14740/cr2080 · Cited by 3
Liu, R., Wang, Z.-Y., Meng, Y.-Y., Chen, W., & Zhou, M. (2025) · Journal of investigative surgery · doi:10.1080/08941939.2025.2500438 · Cited by 3 · see citing works
“Reportedly, remimazolam has an advantage of stable hemodynamics compared with other anesthetics [30].”
Ryo, M., Hayashi, T., Miyasaka, K. W., Yonekura, Y., Fujita, N., & Abe, S. (2025) · Cureus · doi:10.7759/cureus.86592 · Cited by 3
Tian, Z., Yan, T., Bi, Y., Xin, Y., Zhou, S.-Q., Chu, T.-T., & Xu, A. (2025) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2025.05.001 · Cited by 3 · see citing works
“51,52 Based on the results and analysis above, the patients in the R1 and R2 groups achieved a similar sedation efficacy as the patients in the P group.”
Tang, J.-X., Chen, F., Huang, J., Li, D.-L., & Li, C. (2025) · BMJ Open · doi:10.1136/bmjopen-2023-083068 · Cited by 3
Is remimazolam the elusive anesthetic on/off switch?
Renew, J. (2024) · Canadian Journal of Anesthesia/Journal canadien d'anesthésie · doi:10.1007/s12630-024-02736-y · Cited by 3
“15 Its role as a general anesthetic is also being studied and early efforts, such as work from Yim et al. , show promising results.”
Ma, Z.-M., Hu, J.-H., Ying, Y.-Y., Chen, X., Xu, J.-Y., Huo, W.-W., Liu, H., Ji, F.-H., & Peng, K. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23879 · Cited by 3 · see citing works
Salameh, H., Khalili, H., Hashem, W., Assi, S., & Nazzal, Z. A. S. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.07.006 · Cited by 2 · see citing works
Abuelazm, M. T., Alanazi, S. E. T., Altemani, R. F. H., Aljaber, S., Almosa, A., Aljuraifani, A., Alrugaibah, M., Albalawi, M., Alwisiydi, F., & Muawad, R. (2026) · Indian Journal of Anaesthesia · doi:10.4103/ija.ija_908_25 · Cited by 2 · see citing works
“[10] [10–12] In addition, RMZ produces minimal to no pain during injection and displays the antiemetic properties intrinsic to benzodiazepines.”
Li, H., Song, Z., Jiang, X.-W., Liu, W., Jiang, Y., & Wei, R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1714645 · Cited by 2
Kim, H. J., Kim, N., Kim, J., Park, J. H., Shin, H. J., Yang, J.-H., & Kim, S. Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-23469-y · Cited by 2
Jamal, A., Khan, S., Qadri, M., Shah, M. A., Ahmed, U., Iftikhar, H., Uddin, M., Bacha, Z., Khalid, A. A., Khan, A., et al. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001100 · Cited by 2 · see citing works
Shen, J.-J., Wang, L., Liu, Y., Li, T., Zhu, L., Li, Z., Shi, J., & Lv, H. (2025) · Surgery · doi:10.1016/j.surg.2025.109661 · Cited by 2
Lee, J.-M., Lee, J., Kang, S.-H., Jung, K.-H., Yeo, H., & Joo, Y. (2025) · Medicina · doi:10.3390/medicina61091721 · Cited by 2 · see citing works
“Previous studies have consistently shown that remimazolam anesthesia provides stable hemodynamic profiles, often reflected in higher mean arterial pressure compared to other agents [9,12–14 , 22 ].”
Xi, L., Liu, H., Tang, X., & Jiang, Z.-Z. (2025) · Clinical and Translational Science · doi:10.1111/cts.70232 · Cited by 2
“This increases chloride into the neuronal membrane, inhibiting neuronal excitability and producing sedative and analgesic effects [22–24].”
Zhang, X., Li, H.-X., Chen, Y.-R., Wang, B.-N., Zheng, H., & Yan, T. (2025) · BMC Anesthesiology · doi:10.1186/s12871-025-03066-2 · Cited by 2 · see citing works
“…for the induction and maintenance of anesthesia for bronchoscopy [13, 14] and gastrointestinal endoscopy [15–17] and in critically ill [18] and cardiac surgery [19–21] patients, and the results of these studies indicate that, compared with other sedatives, remima-zolam is safe and effective.”
Self-citationRemimazolam in perioperative management of Eisenmenger syndrome: a case report
Hashimoto, K., Matsumoto, T., Mizota, T., Kai, S., & Egi, M. (2024) · JA Clinical Reports · doi:10.1186/s40981-024-00692-6 · Cited by 2
“Another RCT similarly revealed a significantly lower incidence of hypotension in the group using remimazolam for anesthesia induction compared with propofol [5].”
BackgroundResult
- Authors
- Liu, T., Lai, T., Chen, J., Lu, Y., He, F., Chen, Y., & Xie, Y.
- Affiliations
- First Affiliated Hospital of GuangXi Medical University (CN)
- Corresponding author
- Chen, Yanhua
- Xie, Yubo
- Venue
- Pharmacology Research & Perspectives
- Publisher
- Wiley
- Published
- 2021-08-13
- Volume
- 9
- Issue
- 5
- Pages
- e00851-e00851
- ISSN
- 2052-1707 (ISSN-L)
- PMC
- PMC8363771
- OpenAlex
- W3193194912
- Cited by
- 146
- References
- 23
- Citations by year
- 2026: 9 · 2025: 37 · 2024: 37 · 2023: 31 · 2022: 30 · 2021: 2
- FWCI
- 28.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmacology Research & Perspectives (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Guangxi Province (2018GXNSFAA294007)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
- Keywords
- remimazolam, propofol, anesthesia induction, hemodynamic stability, valve replacement, mitral valve replacement, aortic valve replacement, cardiopulmonary bypass, hypotension, bradycardia, norepinephrine requirement, benzodiazepines
- MeSH terms
- Adult, Aged, Aortic Valve, Benzodiazepines, Bradycardia, Cardiopulmonary Bypass, Double-Blind Method, Female, Heart Rate, Hemodynamics, Humans, Hypotension, Intraoperative Complications, Male, Middle Aged, Mitral Valve, Norepinephrine, Sympathomimetics, Propofol, Anesthetics, Intravenous, Heart Valve Prosthesis Implantation, Arterial Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review